These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23888484)

  • 1. Oxygen therapy for cystic fibrosis.
    Elphick HE; Mallory G
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD003884. PubMed ID: 23888484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen therapy for cystic fibrosis.
    Elphick HE; Mallory G
    Cochrane Database Syst Rev; 2009 Jan; (1):CD003884. PubMed ID: 19160226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen therapy for cystic fibrosis.
    Mallory GB; Fullmer JJ; Vaughan DJ
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003884. PubMed ID: 16235344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
    Thaker V; Carter B; Putman M
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD008901. PubMed ID: 30557452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
    Thaker V; Carter B; Putman M
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD008901. PubMed ID: 34424546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
    Thaker V; Haagensen AL; Carter B; Fedorowicz Z; Houston BW
    Cochrane Database Syst Rev; 2015 May; (5):CD008901. PubMed ID: 25991406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity and exercise training in cystic fibrosis.
    Radtke T; Smith S; Nevitt SJ; Hebestreit H; Kriemler S
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD002768. PubMed ID: 35943025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
    Thaker V; Haagensen AL; Carter B; Fedorowicz Z; Houston BW
    Cochrane Database Syst Rev; 2013 Jun; 6(6):CD008901. PubMed ID: 23737090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.
    Carroll W; Green J; Gilchrist FJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD012619. PubMed ID: 34936085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive ventilation for cystic fibrosis.
    Moran F; Bradley JM; Piper AJ
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD002769. PubMed ID: 28218802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatments for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.
    Green J; Gilchrist FJ; Carroll W
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012619. PubMed ID: 29894558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical exercise training for cystic fibrosis.
    Radtke T; Nevitt SJ; Hebestreit H; Kriemler S
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD002768. PubMed ID: 29090734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acid supplementation for cystic fibrosis.
    Watson H; Stackhouse C
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
    McIlwaine M; Button B; Nevitt SJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31774149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise versus airway clearance techniques for people with cystic fibrosis.
    Heinz KD; Walsh A; Southern KW; Johnstone Z; Regan KH
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013285. PubMed ID: 35731672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis.
    Jones M; Moffatt F; Harvey A; Ryan JM
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD013610. PubMed ID: 37462324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin and oral agents for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2016 Apr; 4():CD004730. PubMed ID: 27087121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.